Direxion Daily S&P Biotech Bull 3x Shares Rating $123.11 +7.94 (+6.89%) Closing price 04:10 PM EasternExtended Trading$123.85 +0.74 (+0.60%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.68Holdings in LABU have an aggregate rating of Moderate Buy based on 290 analyst ratings issued in the past year covering 14 companies (12.6% of the portfolio).LABU Aggregate Price Target$123.11High Prediction$123.11Average Prediction$123.11Low Prediction$123.11Holdings in LABU have an aggregate price target of $123.11 and a range of $123.11 to $123.11 covering 14 companies (12.6% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 14 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.07%CRSPCRISPR Therapeutics$73.97+7.0%1.9385 of 5 stars2.42$72.59 -1.9%19Analyst ForecastInsider TradeAnalyst RevisionGap Up0.93%IONSIonis Pharmaceuticals$73.55+0.6%3.2659 of 5 stars2.80$78.50 6.7%200.91%MRNAModerna$27.24+4.7%4.2949 of 5 stars2.00$39.93 46.6%21Analyst ForecastOptions VolumeAnalyst Revision0.91%EXASExact Sciences$62.73+2.4%4.4224 of 5 stars2.92$69.19 10.3%24Analyst Revision0.91%RVMDRevolution Medicines$54.01-0.2%4.4592 of 5 stars2.93$76.67 41.9%15Analyst Forecast0.91%INSMInsmed$167.91+1.3%3.0677 of 5 stars2.86$152.88 -9.0%21Analyst Forecast0.89%UTHRUnited Therapeutics$432.69-0.1%4.7315 of 5 stars2.60$457.21 5.7%15Analyst ForecastInsider Trade0.88%ABBVAbbVie$232.07+1.1%4.594 of 5 stars2.74$234.80 1.2%27Positive NewsAnalyst ForecastAnalyst Revision0.87%AMGNAmgen$303.33+1.5%4.5598 of 5 stars2.32$305.50 0.7%19Positive NewsAnalyst Upgrade0.87%NTRANatera$188.60+3.8%2.1321 of 5 stars2.89$196.81 4.4%19Short Interest ↑0.86%RNAAvidity Biosciences$49.01+2.3%2.6054 of 5 stars2.95$68.32 39.4%20Insider Trade0.86%VRTXVertex Pharmaceuticals$419.10+0.5%4.8193 of 5 stars2.62$494.38 18.0%29Positive News0.85%BBIOBridgeBio Pharma$56.26+2.4%4.4772 of 5 stars2.88$65.06 15.6%17Positive News0.85%EXELExelixis$34.54-12.0%4.9366 of 5 stars2.63$44.42 28.6%24Trending NewsOptions VolumeGap DownHigh Trading Volume This page (NYSEARCA:LABU) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredWhat Wall Street Won’t Say Out LoudDiscover the 7 key indicators before everyone else doesAmerican Alternative | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
